ADARx Pharmaceuticals, Inc.
Status: Publicly traded
Last reviewed: October 2026
Direct answer
ADARx Pharmaceuticals, Inc. is publicly traded on NASDAQ under the ticker ADRX.
ADARx Pharmaceuticals, Inc. is a late-clinical-stage biotechnology company. It focuses on developing next-generation small interfering RNA (siRNA) therapeutics for diseases with significant unmet medical needs. The company was founded by Zhen Li in December 2019 and is headquartered in San Diego, CA.
Can you invest in ADARx Pharmaceuticals, Inc.?
Yes. ADARx Pharmaceuticals, Inc. trades publicly on NASDAQ as ADRX.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for ADARx Pharmaceuticals, Inc.
Detailed equity research is provided by MarketSnap.